The latest happenings of the industry in the past month.
Worldwide Clinical Trials announced the appointment of Clare Wallis as Senior Vice President, Oncology.
PRA Health Sciences, Inc. announced the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President, Scientific and Clinical Affairs.
Chris Wells
Illingworth Research Group has chosen Chris Wells as the new director of their PatientGO patient concierge services.
Trialbee AB announced that Matt Walz has been named as Chief Executive Officer to coincide with the appointment of Lollo Eriksson as Chief Strategy Officer.
SGS announced the recruitment of participants in the US who will be taking part in a multinational trial of a potential drug candidate for those suffering with COVID-19 related respiratory failure.
Parexel, Rho, and THREAD have all joined the Decentralized Trials & Research Alliance.
WorldQuant Predictive has joined The Pistoia Alliance.
McKesson Ventures invested in Clinical Ink.
CluePoints opened a new office in Tokyo.
Oracle announced that the Centers for Disease Control is using their National Electronic Health Records Cloud and Public Health Management Applications Suite to manage the COVID-19 vaccination programs in the US.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.